| Bioactivity | α-Methyl-p-tyrosine is a competitive inhibitor of the enzyme tyrosine hydroxylase, which converts tyrosine to Levodopa (DOPA). α-Methyl-p-tyrosine is an orally active inhibitor of catecholamine synthesis which inhibits the hydroxylation of tyrosine to DOPA[1]. | ||||||||||||
| Name | α-Methyl-p-tyrosine | ||||||||||||
| CAS | 658-48-0 | ||||||||||||
| Formula | C10H13NO3 | ||||||||||||
| Molar Mass | 195.22 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. R N Brogden, et al. alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use. Drugs. 1981 Feb;21(2):81-9. |
α-Methyl-p-tyrosine
CAS: 658-48-0 F: C10H13NO3 W: 195.22
α-Methyl-p-tyrosine is a competitive inhibitor of the enzyme tyrosine hydroxylase, which converts tyrosine to Levodopa
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.